Search results will open in a new window on TMXMoney.com.

Exchange Bulletin

Crescita Therapeutics Inc. (CTX) To Trade On Toronto Stock Exchange


February 29, 2016

Crescita Therapeutics Inc. (the “Company”) – An application has been granted for the original listing in the Industrial category of approximately 12,708,883 common shares (“Common Shares”) of the Company, of which approximately 11,463,769 Common Shares will be issued and outstanding and approximately 1,245,114 Common Shares will be reserved for issuance.

As described in today’s Toronto Stock Exchange (“TSX”) Bulletin regarding Nuvo Research Inc. (“Nuvo”) (Symbol: NRI), holders of common shares of Nuvo (“Nuvo Shares”) of record as of the close of business on Thursday, March 3, 2016 (the “Record Date”) will receive one Common Share of the Company for every Nuvo Share held (the “Arrangement”). It is understood that certificates representing Common Shares will be mailed commencing on or about March 4, 2016 to holders of Nuvo Shares on the Record Date.

The Common Shares of the Company will be listed and posted for trading at the opening of business on Monday, March 7, 2016.

The Company is subject to the reporting requirements of Section 501 of the TSX Company Manual.

Stock Symbol: "CTX" CUSIP: 225847 10 2 Trading Currency: CDN$

 

Designated Market Maker: Independent Trading Group
Head Office Address: 7560 Airport Road, Unit 10
Mississauga, Ontario
L4T 4H4
Head Office Telephone Number: (905) 673-4295
Fax Number: (905) 677-1881
Toll Free Number: 1-888-273-0830
Email Address: ir@crescitatx.com
Website: www.crescitatherapeutics.com
Investor Relations: Stephen Lemieux
Vice President and Chief Financial Officer
Tel: (905) 673-4271
slemieux@nuvoresearch.com

- or -

Investor Relations
Tel: (905) 673-4297
Email: ir@crescitatx.com
Incorporation: The Company was incorporated under the Business Corporations Act (Ontario) on October 14, 2015.
Fiscal Year End: December 31
Nature of Business: The Company is a drug development company with a diversified pipeline of product candidates.
Chief Financial Officer: Stephen L. Lemieux
Corporate Secretary: Katina K. Loucaides
Transfer Agent & Registrar: CST Trust Company at its principal offices located in Toronto.
Dividends: The Company does not anticipate paying dividends for the foreseeable future.